Average Co-Inventor Count = 2.51
ph-index = 52
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Pennsylvania (164 from 2,551 patents)
2. Analog Devices,inc. (32 from 3,604 patents)
3. Other (17 from 832,347 patents)
4. Whitehead Institute for Biomedical Research (6 from 302 patents)
5. University of Michigan (4 from 3,325 patents)
6. The Wistar Institute of Anatomy & Biology (3 from 157 patents)
7. Howard Hughes Medical Institute (2 from 116 patents)
8. Mra Laboratories, Inc. (2 from 9 patents)
9. The Brigham and Women's Hospital, Inc. (1 from 1,359 patents)
10. Janssen Biotech, Inc. (1 from 402 patents)
11. New England Medical Center Hospitals. Inc. (1 from 97 patents)
12. Somatix Therapy Corporation (1 from 2 patents)
13. Howard Hughes Medical Center (1 from 1 patent)
227 patents:
1. 12428653 - Gene therapy for ceroid lipofuscinoses
2. 12416016 - Adeno-associated virus (AAV) vectors, AAV vectors having reduced capsid deamidation and uses therefor
3. 12416017 - Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration
4. 12385065 - Gene therapy for treating citrullenemia
5. 12338451 - Compositions useful in treatment of metachromatic leukodystrophy
6. 12221615 - GLP-1 and use thereof in compositions for treating metabolic diseases
7. 12023386 - Composition for treatment of Crigler-Najjar syndrome
8. 11890329 - AAV9-mediated gene therapy for treating mucopolysaccharidosis type I
9. 11865187 - Methods and compositions for treating metastatic breast cancer and other cancers in the brain
10. 11827906 - Adeno-associated virus (AAV) clade f vector and uses therefor
11. 11819539 - Gene therapy for treating Mucopolysaccharidosis type II
12. 11807866 - Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof
13. 11779656 - Gene therapy for treating hemophilia A
14. 11766448 - Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer
15. 11732246 - Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency